In-Video Drug Ads on YouTube: Should They be "Non-Skippable?"

Yesterday, I wanted to cook stuffed artichokes for dinner. So, I searched Google for a video and found this on YouTube: "ITALIAN STUFFED ARTICHOKES - SICILIAN STYLE - EASTER DINER RECIPE."

Before the cooking lesson started, there was an in-video ad for an Rx drug, the name of which I can't recall right now. No matter. After 15 seconds or so I realized I could click on "Skip Ad" and not hear any more of the side effects, aka FDA-required Important Safety Information (ISI), "major statement," and "Fair Balance" stuff that is usually crammed into Direct-to-Consumer (DTC) TV ads after about 20 or 30 seconds.

Ruth Day of Duke University once said of print and TV DTC drug ads (here): “Risk information is physically present but functionally absent.” This accurately describes what's happening in skippable in-video DTC ads on Youtube.

According to YouTube Help, there are two versions of in-video ads: (1) skippable ads like the one I saw, and (2) non-skippable ads.

It seems that pharma uses only the former, not the latter. Is this acceptable?

Read more »

History of the Pharmaguy Pioneer Hawaiian Shirt

The yellow and black Hawaiian shirt is the symbol of the Pharmaguy Social Media Pioneer Award, better known as the “Pharmaguy Pioneer Award” for short.

What began as an outlandish ploy to grab attention has gradually become one of the most iconic and recognizable trophies in digital pharmaceutical marketing.

After the U.S. Food and Drug Administration (FDA) announced it would hold a public hearing regarding regulation of pharma's use of the Internet and social media in November, 2009 (here), Pharmaguy started appearing at conferences in the iconic shirt, which was left over from a Hunter S. Thompson Halloween costume (here).

Left: Pharmaguy as Hunter S. Thompson at a 2009 Halloween party.
Right: Pharmaguy at the 3rd Annual Digital Pharma East "un" conference
(there is some controversy regarding the sequence of these events)

That Halloween season was a scary time and attendees of the 3rd Annual Digital Pharma East "un" conferences anticipated much "fear in loathing" in Washington, DC at the upcoming FDA hearing!

Read more »

AMA #AHealthierNation Tweet Chat: How to Get Physicians Involved in Development of Digital Tools

Yesterday, while trolling my Twitter streams for content, I happened upon #AHealthierNation chat sponsored by the American Medical Association (AMA). According to AMA's promo page (here):

"The potential impact of digital technology on health care is undeniable. Our tweet chat examined the role physicians should play in shaping the future of digital medicine and how new innovations can enhance workflow and expand the physician-patient relationship."

According to symplur analytics, the chat included over 100 participants, more than 500 tweets, and 22.4 million impressions! I was responsible for 10 tweets, which garnered 239,000 impressions.

Seven questions were up for discussion:

1. How do you get physicians involved in the development of tools for digital medicine?
2. Not everyone can be an inventor, so where do physician feedback opportunities exist?
3. Have too many digital solutions overlooked the basics of a physician's workflow and the need to create efficiencies?
4. With user-centered design, what are the biggest challenges for two very different users: physicians and patients?
5. For a patient, what does engagement look like? How has the attention around wearables figured into that definition?
6. What are the obstacles that must be addressed for wearable to receive broader physician adoption?
7. What do we need to learn to make digital health/medicine a success in the future?

Questions 1, 2, 3, 5, and 6 generated the most discussion. Here's my synopsis/review (see the complete #AHealthierNation tweet timeline embedded at the end of this post).

Read more »

Is Martin Shkreli a Psychopath?

Martin Shkreli, CEO of Turing Pharmaceuticals, is a former hedge fund manager who has become the public face of the drug pricing controversy after his company raised the price of the anti-infection drug Daraprim by more than 5,000 percent.

Now the Senate’s special committee on aging requested documents and information from Turing and invited Shkreli to testify.

Shkreli taunted politicians on Tweeter days before the Senate invite, saying he was "In DC. If any politicians want to start, come at me" (read "Senate Invites Turing CEO Shkreli to Visit. Just What He Wanted!") - a taunt typical of a Psychopath. Indeed, Shkreli has been called a "morally bankrupt sociopath," a "greedy sociopath," a "sociopathic bounty hunter," and an "evil sociopathic asshole."

I don't think Shkreli is a sociopath - I think he better fits the profile of a psychopath. To find out, I took a PsychCentral "Psychopathy Quiz" posing as Shkreli and supplying answers I thought indicative of his behavior. So, how did he score?

Read more »

Yeah, Market Research Still Matters...

Successful businesses have expansive knowledge about their competitors and customers. Market research is the process of gathering market data about the current and potential customers to enable you react to the potential or current products or services. Many small businesses carry out market research without even knowing they are doing so. For instance, when a small business owner inquires from customers about how they feel about the services offered, or a business owner checks competitor product prices, then he/she is conducting market research.

The main aim of market research is to prepare for the marketing research report. Marketing research report includes a summary of the important data and analysis of the data for decision making in the business. Market research has been enhanced with the advent of the internet which makes it possible to reach the target market quickly and with ease and still gain important consumer knowledge to drive business forward.

The main questions property decision makers would want to ask themselves is - is there a useful way to conduct market research for a property business to make informed decisions about the way forward? And why is market research important? These questions can be answered by understanding how effective and efficient market research can be to help business find the opportunities and strengths, and where to eliminate opportunities to help the business expand.

Let’s start with why is market research important? Market research defines a clear direction for a company. When market research is done effectively and market research report is prepared well, businesses have a clear view of the customer needs and a clear path which the company need to take to achieve the needs of the prospective customers. Unfortunately, many small businesses may not be in a position spend the thousands of dollars to hire the most reputable market research firms. In this regard, many of them prefer to ignore taking market research into consideration or use approaches which may not lead to useful information.

The importance of market research include helping to understand the market, which may include the target age bracket, target gender and other demographics. Market research is critical to understand the competition, know the right product customers need and building connections.

Big Data has been a game charger as far as market research is concerned. Market researchers are faced with large amounts of data to analyze and monitor both online and offline to understand the customer needs. In this regard, Big Data is continually being used by researchers as a compliment to market research to know what consumers need and monitor changes in tastes and preferences. The five insights gained include - creating a more accurate profile of the target customers, to monitor and analyze the consumer reaction to product offerings and marketing messages, develop strategies for retaining customers in a more effective and efficient way, plan marketing campaigns and digital marketingto the target groups and monitor changes in tastes and preferences.

Queensland property market is currently a BOOM market thanks to Queensland’s economy which has started to improve. For instance, the latest RP Data CoreLogic Home Value Index for Brisbane show an increase of 0.7% for September 2014, 0.6% increase over the last quarter of 2014 and 6.4% year-to-year increase. Small businesses investing in Queensland property market should use these kinds of market data and outsource market research from property research companies to achieve real value of their investment.

This post comes from Sarah, an inspirational writer. She is part of crews at Real Estate Academy Australia (a specialized training center for the real estate industry), working with entrepreneurs and small business owner to grow their careers and achieve results that raise the standards of professionalism and respect in the Real Estate industry.

The Value of Medical Content Channels According to HCPs vs Pharma Professionals

A study conducted from July – August 2015 by EPG Health Media, publisher of epgonline.org (a website for healthcare professionals) found some "significant gaps and imbalances" between how healthcare professionals (HCPs) and pharma industry professionals (Pharma) view the value of medical content delivery channels.

Keep in mind that the results are based on a very limited number of survey participants, which include 216 HCPs and 137 pharmaceutical industry professionals (66 pharmaceutical professionals and 71 service providers).

I selected a few channels to look at (mostly digital) and replotted the data in the following chart, which shows the percent of respondents (HCPs v. Pharma) who consider that the channels have moderate or significant value for HCPs.

Click on image for an enlarged view.

What are the key takeaways from this study?

Read more »

Relaxing Rules for Off-Label Prescribing: "Akin to Crying 'Fire!' in a Crowded Theater?"

In the Amarin court case, the court ruled that the company has the right, under the First Amendment, to promote information to health-care professionals about certain uses of the drug Vascepa that aren't covered by the drug's FDA-approved labeling -- as long as the information is true and not misleading (read "Amarin Wins Off-Label Case Against FDA"). This case is likely to influence new guidance from the FDA regarding off-label drug promotion by pharma marketers.

"Might changes in rules for promotion of off-label indications based on free speech arguments lead to a situation akin to crying fire in a crowded theater?," asks authors of Commentary published in the recent issue of JAMA Internal Medicine. The authors of the commentary -- Chester B. Good, M.D., M.P.H., and Walid F. Gellad, M.D., M.P.H., of the Veterans Affairs Pittsburgh Heathcare System -- referred to "compelling evidence" that "off-label prescribing is frequently inappropriate and that prescribing in these circumstances increases the risk for an adverse event substantially."

That evidence was presented in a study published in the same issue of the journal titled "Off-label Prescription Drug Use and Adverse Drug Events" (JAMA Intern Med. Published online November 2, 2015. doi:10.1001/jamainternmed.2015.6058).

What is the "compelling evidence?"

Read more »